Target intelligence / Profile preview

Potassium inwardly rectifying channel subfamily J member 10 (KCNJ10) (Kir4.1)

Target
Kir4.1
Molecular classification
Ion channel, Inwardly rectifying potassium channel, Kir family
01

Overview

The Flicker potassium channel, molecularly identified as the Potassium inwardly rectifying channel subfamily J member 10 (KCNJ10 or Kir4.1), is a crucial ion channel primarily located in the basolateral membrane of the renal thick ascending limb and distal convoluted tubule, as well as in glial cells of the central nervous system (UniProt P78508; PubMed 25634686). In the kidney, it often functions as a heteromer with Kir5.1, providing the necessary potassium conductance for the Na+/K+-ATPase to maintain the electrochemical gradient required for sodium and magnesium reabsorption (PubMed 10449505). In the brain, Kir4.1 is responsible for potassium spatial buffering, a process where astrocytes remove excess extracellular potassium generated during neuronal activity to prevent over-excitability (PubMed 15165731). Mutations in the gene encoding this channel lead to EAST (Epilepsy, Ataxia, Sensorineural deafness, and Tubulopathy) syndrome, highlighting its multi-organ importance (NEJM 360:1960-70). Pharmacologically, the channel is sensitive to various compounds including barium, quinine, and certain antidepressants like fluoxetine, which inhibit its activity and are used as tools to study its role in epilepsy and hypertension (PubMed 17606554).

Other names
Flicker potassium channelFlicker-type K+ channelKCNJ10Inward rectifier K+ channel Kir4.1BIRK10ATP-sensitive inward rectifier potassium channel 10
02

Mechanism of action

Inhibition of Kir4.1 reduces basolateral potassium conductance in the kidney, impairing sodium reabsorption and magnesium transport. In the CNS, inhibition or loss of function disrupts glial potassium spatial buffering, leading to increased neuronal excitability.

03

Biological functions

Potassium homeostasisResting membrane potential maintenanceTransepithelial transportGlial potassium bufferingGlutamate uptake regulationMagnesium reabsorption
04

Disease associations

EAST syndromeSeSAME syndromeHypertensionEpilepsyAmyotrophic lateral sclerosis (ALS)Hypomagnesemia
05

Safety considerations

HypokalemiaHypomagnesemiaMetabolic alkalosisSeizuresSensorineural hearing lossAtaxia
06

Interacting drugs

Barium

6 more in the full profile.

07

Biomarkers

Serum magnesium levelsSerum potassium levelsKCNJ10 genetic mutations

Beyond the preview

Go deeper on Potassium inwardly rectifying channel subfamily J member 10 (KCNJ10) (Kir4.1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Potassium inwardly rectifying channel subfamily J member 10 (KCNJ10) (Kir4.1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call